The News Center of the Feinberg School of Medicine released their 2013 Year in Review highlighting the growth and success of the previous year. A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists, including our very own Dr. Teresa Woodruff, to be less toxic to a young woman’s fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
